News

February 19, 2021

Innovative Medicines Canada responds to calls for disclosure of proprietary business information

IMC issued the following statement in response to calls for the disclosure […]

February 2, 2021

Innovative Medicines Canada statement regarding EU export mechanism for COVID-19 vaccines

IMC issued the following statement […]

November 25, 2020

Statement: COVID-19 Vaccine Manufacturing Capacity

IMC issued the following statement today in response to questions […]

August 5, 2020

Meet the Experts: Dr. Doron Sagman

Dr. Doron Sagman is Lilly Canada’s Vice President of R&D and Medical Affairs as well as Lilly’s Senior Medical Director. Doron is a physician with nearly 20 years of experience […]

July 29, 2020

Health Research Foundation awards Research Chair in Pandemic Preparedness Research to UBC professor

The Health Research Foundation of IMC is pleased to […]

June 3, 2020

Meet the experts: Dr. Alex Romanovschi

Dr. Alex Romanovschi is GSK Canada’s Country Medical Director. Alex is a physician with nearly 20 years of experience in the pharmaceutical industry spanning many therapeutic areas, including cardiovascular diseases, […]

May 25, 2020

IMC announces creation of Research Chair in Pandemic Preparedness

IMC today announced the creation of a Research Chair in pandemic preparedness […]

May 20, 2020

Meet the experts: Vatche Bartekian

Vatche is the President and Founder of Vantage BioTrials, a Canadian CRO specialized in clinical trial management services. He’s contributed his strong drug development knowledge to the pharma and clinical […]

May 13, 2020

Meet the experts: Dion Neame

Dion Neame is the Country Medical Lead for Sanofi Canada and Country Medical Head for Pasteur, the vaccine arm of Sanofi. He is also a pediatrician working in Pediatric Urgent […]

May 12, 2020

Canada’s innovative medicines industry supporting patients, healthcare workers during COVID-19 outbreak

In response to the global outbreak of COVID-19 […]

May 11, 2020

IMC welcomes federal Industry Strategy Council and looks forward to helping promote innovation, economic inclusion and growth

IMC released the following statement […]

May 6, 2020

The SOLIDARITY Trial

Canada’s involvement in a “global megatrial” to quickly identify treatments for COVID-19 […]

April 28, 2020

IMC members donate funds for protective equipment for Canada’s pharmacists

Members of Innovative Medicines Canada continue to support front line workers […]

April 27, 2020

World Immunization Week

WIW is an opportunity for the global community […]

April 23, 2020

IMC welcomes additional investment by the federal government in research, clinical trials and testing for COVID-19

IMC welcomes today’s announcement by the federal […]

April 22, 2020

COVID-19 Treatments

Despite the bad news related to COVID-19, there are some glimmers of hope. Health experts are reporting signs that the infection curve in Canada may be starting to flatten, while […]

April 20, 2020

Compliance with IMC Code of Ethical Practices during
COVID-19

The Canadian innovative pharmaceutical industry […]

April 8, 2020

Unprecedented collaboration in the fight against COVID-19

A global pandemic of unprecedented proportions demands […]

April 1, 2020

IMC members donate 100,000 masks to protect healthcare workers

Members of IMC are continuing their efforts in the fight against COVID-19 […]

April 1, 2020

Innovative Medicines Canada members donate 100,000 masks to help protect front-line healthcare workers battling COVID-19

Ottawa, April 1, 2020—Members of Innovative Medicines Canada (IMC) are continuing their efforts in the fight against COVID-19 by donating 100,000 KN95 masks for front-line healthcare workers battling the virus. […]

March 23, 2020

The Complex Journey of a Vaccine

Canada’s innovative pharmaceutical industry is coming together to achieve one shared goal: the eradication of COVID-19. We are committed to and focused on creating new tests for the virus, on […]